Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 7
Results: 18
1
2
Alterations in cellular metabolisms after Imatinib therapy: a review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
3
Combinational treatment of TPEN and TPGS induces apoptosis in acute lymphoblastic and chronic myeloid leukemia cells in vitro and ex vivo.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
Cell line models for drug discovery in PIK3CA-mutated colorectal cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
5
The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
6
Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
- Published in:
- 2022
- By:
- Publication type:
- journal article
8
TMCO1 expression promotes cell proliferation and induces epithelial-mesenchymal transformation in human gliomas.
- Published in:
- 2022
- By:
- Publication type:
- journal article
9
Engineering tumor-derived small extra cellular vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell proliferation, migration, and gene expression.
- Published in:
- 2022
- By:
- Publication type:
- journal article
10
The role of histone deacetylase 3 in breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
11
Long non-coding RNAs and cancer mechanisms: Immune cells and inflammatory cytokines in the tumor microenvironment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
12
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
13
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.
- Published in:
- Medical Oncology, 2022, v. 39, n. 7, p. 1, doi. 10.1007/s12032-022-01671-6
- By:
- Publication type:
- Article
14
Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
- Published in:
- Medical Oncology, 2022, v. 39, n. 7, p. 1, doi. 10.1007/s12032-022-01670-7
- By:
- Publication type:
- Article
15
The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
16
Heme-regulated inhibitor: an overlooked eIF2α kinase in cancer investigations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
17
A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.
- Published in:
- 2022
- By:
- Publication type:
- journal article
18
20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article